DEXCOM, INC. Income (Loss) from Continuing Operations, Per Diluted Share
DEXCOM, INC. (DXCM) reported Income (Loss) from Continuing Operations, Per Diluted Share of $0.02 per share for the 3-month period ending 2015-12-31, per its 10-K filed 2016-02-23.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2016-02-23
- DEXCOM, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2015-12-31 was $0.02, a 0.00% change year-over-year.
- DEXCOM, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2015-09-30 was -$0.53.
- DEXCOM, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2015-06-30 was -$0.05.
- DEXCOM, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2015-03-31 was -$0.17.
| Period end | Income (Loss) from Continuing Operations, Per Diluted Share 3 month | Income (Loss) from Continuing Operations, Per Diluted Share 6 month | Income (Loss) from Continuing Operations, Per Diluted Share 9 month |
|---|---|---|---|
| 2015-12-31 | $0.02 10-K · filed 2016-02-23 | ||
| 2015-09-30 | -$0.53 10-K · filed 2016-02-23 | -$0.75 10-Q · filed 2015-11-04 | |
| 2015-06-30 | -$0.05 10-K · filed 2016-02-23 | -$0.21 10-Q · filed 2015-08-05 | |
| 2015-03-31 | -$0.17 10-K · filed 2016-02-23 | ||
| 2014-12-31 | $0.02 10-K · filed 2016-02-23 | ||
| 2014-09-30 | -$0.08 10-K · filed 2016-02-23 | -$0.33 10-Q · filed 2015-11-04 | |
| 2014-06-30 | -$0.09 10-K · filed 2016-02-23 | -$0.25 10-Q · filed 2015-08-05 | |
| 2014-03-31 | -$0.17 10-K · filed 2016-02-23 | ||
| 2013-09-30 | -$0.08 10-Q · filed 2014-11-06 | -$0.38 10-Q · filed 2014-11-06 | |
| 2013-06-30 | -$0.14 10-Q · filed 2014-08-06 | -$0.30 10-Q · filed 2014-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |